Franklin Resources’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
24,203
-24,239
-50% -$276K ﹤0.01% 2714
2026
Q1
$551K Buy
48,442
+83
+0.2% +$899 ﹤0.01% 2433
2025
Q4
$621K Buy
48,359
+1,076
+2% +$13.3K ﹤0.01% 2306
2025
Q3
$528K Sell
47,283
-24,001
-34% -$232K ﹤0.01% 2401
2025
Q2
$707K Buy
71,284
+99
+0.1% +$969 ﹤0.01% 2164
2025
Q1
$668K Buy
71,185
+24,667
+53% +$259K ﹤0.01% 2143
2024
Q4
$426K Sell
46,518
-15,266
-25% -$112K ﹤0.01% 2360
2024
Q3
$399K Sell
61,784
-1,502
-2% -$10.8K ﹤0.01% 2379
2024
Q2
$383K Sell
63,286
-1,191
-2% -$7.35K ﹤0.01% 2345
2024
Q1
$378K Buy
+64,477
New +$383K ﹤0.01% 2379
2023
Q3
Sell
-11,820
Closed -$123K 2664
2023
Q2
$123K Buy
+11,820
New +$114K ﹤0.01% 2501

Other funds holding ANGO

Franklin Resources's ANGO Position: Q2 2026 in Review

Franklin Resources reduced its AngioDynamics (ANGO) stake by 50% in Q2 2026, selling an estimated $276K and leaving 24,203 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

Franklin Resources first reported a position in ANGO in Q2 2023 and has held it in 11 quarters since. The position peaked at $707K in Q2 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Franklin Resources held 24,203 shares of AngioDynamics worth $315K as of Q2 2026.
  • Franklin Resources sold 24,239 AngioDynamics shares in Q2 2026, an estimated $276K.
  • AngioDynamics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2714 holding.
  • Franklin Resources first reported a position in AngioDynamics in Q2 2023 and has held it in 11 quarters since.
  • Franklin Resources's AngioDynamics position peaked at $707K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.